sinefungin has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Alcaraz, J; Baulida, J; Curto, J; Duch, P; Franco-Valls, H; García de Herreros, A; Peña, R; Sala, L; Stanisavljevic, J; Vergés, J | 1 |
| Agnamey, P; Ballet, JJ; Brasseur, P; Favennec, L; Leméteil, D; Li, X; Rossignol, JF | 1 |
| Ding, M; Toth, LA | 1 |
| Ballet, JJ; Brasseur, P; Favennec, L; Leméteil, D; Roussel, F | 1 |
| Avila, JL; Convit, J; Monzón, H; Rojas, T | 1 |
6 other study(ies) available for sinefungin and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Abrogation of myofibroblast activities in metastasis and fibrosis by methyltransferase inhibition.
Topics: Adenosine; Animals; Breast Neoplasms; Cancer-Associated Fibroblasts; Cell Line, Tumor; Cell Transdifferentiation; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Deletion; Humans; Idiopathic Pulmonary Fibrosis; Lung Neoplasms; Methyltransferases; Mice; Myofibroblasts; Snail Family Transcription Factors; Transforming Growth Factor beta; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2019 |
Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model.
Topics: Adenosine; Animals; Antiprotozoal Agents; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Feces; Immunocompromised Host; Male; Nitro Compounds; Parasite Egg Count; Paromomycin; Rats; Rats, Sprague-Dawley; Thiazoles | 2003 |
mRNA expression in mouse hypothalamus and basal forebrain during influenza infection: a novel model for sleep regulation.
Topics: Acute-Phase Proteins; Adenosine; Animals; Disease Models, Animal; Hypothalamus; Intramolecular Oxidoreductases; Lipocalin-2; Lipocalins; Male; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Models, Biological; Oncogene Proteins; Orthomyxoviridae Infections; Prosencephalon; Receptors, Corticotropin-Releasing Hormone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sleep | 2006 |
An immunosuppressed rat model for evaluation of anti-Cryptosporidium activity of sinefungin.
Topics: Adenosine; Animals; Coccidiostats; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Feces; Immunocompromised Host; Lasalocid; Male; Rats; Rats, Sprague-Dawley | 1994 |
Sinefungin as treatment for American Leishmania in sensitive BALB/c and resistant C57BL/6 mice.
Topics: Adenosine; Animals; Antiprotozoal Agents; Cells, Cultured; Disease Models, Animal; Immunity, Innate; Leishmania; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Structure | 1990 |